Ginsenoside Rb1 Reduces Neurodegeneration in the Peri-infarct Area of a Thromboembolic Stroke Model in Non-human Primates

Ginsenoside Rb1 (GRb1), a major component of the traditional herb ginseng, has been reported to show a neuroprotective effect in a rodent ischemic model. The purpose of this study was to investigate effects of GRb1 on early and delayed brain injuries in a non-human primate thromboembolic stroke mode...

Full description

Saved in:
Bibliographic Details
Main Authors: Tetsuya Yoshikawa (Author), Yuki Akiyoshi (Author), Teruo Susumu (Author), Hiroshi Tokado (Author), Koichiro Fukuzaki (Author), Ryoichi Nagata (Author), Keiichi Samukawa (Author), Hiroshi Iwao (Author), Go Kito (Author)
Format: Book
Published: Elsevier, 2008-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cdfcaed3dcae47549dbe56f415bedd2c
042 |a dc 
100 1 0 |a Tetsuya Yoshikawa  |e author 
700 1 0 |a Yuki Akiyoshi  |e author 
700 1 0 |a Teruo Susumu  |e author 
700 1 0 |a Hiroshi Tokado  |e author 
700 1 0 |a Koichiro Fukuzaki  |e author 
700 1 0 |a Ryoichi Nagata  |e author 
700 1 0 |a Keiichi Samukawa  |e author 
700 1 0 |a Hiroshi Iwao  |e author 
700 1 0 |a Go Kito  |e author 
245 0 0 |a Ginsenoside Rb1 Reduces Neurodegeneration in the Peri-infarct Area of a Thromboembolic Stroke Model in Non-human Primates 
260 |b Elsevier,   |c 2008-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.FP0071297 
520 |a Ginsenoside Rb1 (GRb1), a major component of the traditional herb ginseng, has been reported to show a neuroprotective effect in a rodent ischemic model. The purpose of this study was to investigate effects of GRb1 on early and delayed brain injuries in a non-human primate thromboembolic stroke model. Thromboembolic stroke was induced by occlusion of the middle cerebral artery by injection of an autologous blood clot into the left internal carotid artery. GRb1 (300 µg/kg per day, i.v.) and vehicle were administered from 7 days before embolization to the day following embolization (total: 8 times). Neurological deficits were observed at 1, 6, and 24 h and at 2, 4, and 7 days after embolization. At 7 days after embolization, neuron damage in the peri-infarct area and core region were assessed by NeuN, TUNEL, and GFAP staining. GRb1 improved the skeletal muscle coordination score of the neurologic deficits (median: GRb1 vs vehicle = 10 vs 12, P<0.05). In the GRb1 group, positive neurons expressed by NeuN staining were noted in the ischemic peri-infarct area, and TUNEL- and GFAP-positive cells significantly decreased, when compared with vehicle. These results demonstrated that GRb1 ameliorated both early and delayed injuries in the thromboembolic stroke model in non-human primates. Keywords:: experimental thromboembolic stroke, ginsenoside Rb1, neurologic deficit, cynomolgus monkey 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 107, Iss 1, Pp 32-40 (2008) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319314525 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/cdfcaed3dcae47549dbe56f415bedd2c  |z Connect to this object online.